biote vs FitLife Brands
BTMD and FTLF side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BTMD and FTLF compare
FitLife Brands is the larger company, worth 2.1 times as much as biote ($79.6M against $38.3M).
FitLife Brands keeps more of each dollar of sales as profit, with a net margin of 1.9% compared with −1.1% at biote.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BTMD | FTLF |
|---|---|---|
| Size and price | ||
| Market cap | $38.3M | $79.6M |
| Share price | $1.06 | $8.48 |
| Change, 1 year | −59.7% | −55.3% |
| Change, 5 years | −89.1% | 38.3% |
| Beta (5Y) | 0.51 | 0.28 |
| Employees | 223 | 39 |
| StockData Score | ||
| Total score | 4 | 4 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 2 | 2 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 44.6× |
| P/S | 0.2× (better) | 0.8× |
| P/B | – | 1.7× |
| EV/EBITDA | 12.2× (better) | 17.9× |
| P/FCF | 5.2× (better) | 7.9× |
| FCF yield | 19.4% (better) | 12.6% |
| Fair value | – | $7.13 |
| Margin of safety | – | −18.9% |
| Growth | ||
| Revenue growth (TTM) | −8.6% | – |
| Revenue growth, 5Y average | – | −6.3% |
| Net income growth (TTM) | −107% | – |
| EPS growth (TTM) | −114% | – |
| EPS growth, 5Y average | – | −27.1% |
| Profitability | ||
| Gross margin | 67.5% (better) | 12.3% |
| Operating margin | 5.0% (better) | 3.8% |
| Net margin | −1.1% | 1.9% (better) |
| FCF margin | 4.1% | 9.9% (better) |
| Return on equity | – | 4.4% |
| Return on invested capital | 18.5% (better) | 6.1% |
| Financial health | ||
| Net debt / EBITDA | 8.62 | – |
| Interest coverage | – | 3.4× |
| Current ratio | 1.37 | 1.46 (better) |
| Altman Z-score | 1.65 | 2.30 (better) |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | 18.9% | – |
| Shareholder yield | 18.9% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 36.6% | 6.8% |
| Held by insiders | 23.3% | 59.1% |
| Insider net buying, 12 months | $202K (better) | $74.5K |
| Short interest, % of float | 3.1% | 1.7% |
Go deeper
- BTMD stock overview
- BTMD income statement
- BTMD valuation and score
- FTLF stock overview
- FTLF income statement
- FTLF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.